Phenotypic Characterization of Idiosyncratic Drug-Induced Liver Injury: The Influence of Age and Sex

被引:234
|
作者
Isabel Lucena, M. [1 ]
Andrade, Raul J. [2 ]
Kaplowitz, Neil [3 ]
Garcia-Cortes, Miren [2 ]
Carmen Fernandez, M. [4 ,5 ]
Romero-Gomez, Manuel [6 ]
Bruguera, Miguel [7 ]
Hallal, Hacibe [8 ]
Robles-Diaz, Mercedes [2 ]
Rodriguez-Gonzalez, Jose F. [9 ]
Maria Navarro, Jose [9 ]
Salmeron, Javier [10 ]
Martinez-Odriozola, Pedro [11 ]
Perez-Alvarez, Ramon [12 ]
Borraz, Yolanda [1 ]
Hidalgo, Ramon [13 ]
机构
[1] Univ Hosp Virgen Victoria, Clin Pharmacol Serv, Malaga, Spain
[2] Univ Hosp Virgen Victoria, Sch Med, Liver Unit, Malaga, Spain
[3] USC Res Ctr Liver Dis, Keck Sch Med, Los Angeles, CA USA
[4] Hosp Torrecardenas, Clin Pharmacol Serv, Almeria, Spain
[5] Hosp Torrecardenas, Digest Unit, Almeria, Spain
[6] H Valme, Gastroenterol Serv, Seville, Spain
[7] H Clin, Liver Unit, Barcelona, Spain
[8] H Morales Meseguer, Gastroenterol Serv, Murcia, Spain
[9] H Costa Del Sol, Gastroenterol Serv, Marbella, Spain
[10] H San Cecilio, Gastroenterol Serv, Granada, Spain
[11] H Basurto, Dept Internal Med, Bilbao, Spain
[12] H Cent Asturias, Gastroenterol Serv, Oviedo, Spain
[13] Univ Malaga, Ctr Informat Technol, Malaga, Spain
关键词
CLINICAL-FEATURES; AMOXICILLIN; HEPATOTOXICITY; SUSCEPTIBILITY; COMBINATION; DISEASES; REGISTRY; GENDER;
D O I
10.1002/hep.22895
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Increased age and female sex are suggested risk factors for drug-induced hepatotoxicity (DILI). We studied the influence of these variables on the propensity to develop DILI, as well as its clinical expression and outcome. All cases of DILI submitted to the Spanish Registry between April 1994 and August 2007 were analyzed. Six hundred three DILI cases (310 men; mean age, 54 years) showed a similar sex distribution, reaching two peaks in the 40- to 49-year-old and 60- to 69-year-old age groups. No cases were recorded in the 20- to 29-year-old group. Patients aged >= 60 years accounted for 46% of the cases, with a male predominance (158 males, 118 females; P = 0.009), as opposed to younger patients. Older age was independently associated with cholestatic type of injury (odds ratio for an age interval for 1 year: 1.024 [95% confidence interval: 1.010-1.038]; male/female ratio, 1:2; P = 0.001) and younger age with hepatocellular damage (odds ratio: 0.983 [95% confidence interval: 0.972-0.994]; female/male ratio, 1:2; P = 0.002). In the mixed group, no age effect was evident. Outcome with fluminant liver failure/liver transplantation was more frequently encountered in women (P < 0.01). Conclusion: Neither older age nor female sex are predisposing factors to overall DILI. However, older age is a determinant for cholestatic damage with a male predominance, whereas younger age is associated with cytolytic damage and a female overrepresentation. Women distinctly exhibit the worst outcome. Knowledge of these phenotypic associations could guide differential diagnosis and attribution of causality in DILI. (HEPATOLOGY 2009;49:2001-2009.)
引用
收藏
页码:2001 / 2009
页数:9
相关论文
共 50 条
  • [21] CELLULAR AND ANIMAL MODELS OF IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY
    Yokoi, Tsuyoshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S4 - S5
  • [22] Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives
    Fontana, Robert J.
    GASTROENTEROLOGY, 2014, 146 (04) : 914 - U437
  • [23] Methods for causality assessment of idiosyncratic drug-induced liver injury
    Garcia-Cortes, Miren
    Matilla-Cabello, Gonzalo
    Lucena, M. Isabel
    LIVER INTERNATIONAL, 2025, 45 (03)
  • [24] The impact of age on phenotype presentation and severity in patients with idiosyncratic drug-induced liver injury (DILI)
    Slim, Mahmoud
    Robles-Diaz, M.
    Ortega, A.
    Garcia-Cortes, Miren
    Medina-Caliz, I.
    Garcia-Munoz, Beatriz
    Sanjuan-Jimenez, R.
    Gonzalez-Jimenez, A.
    Ibanez, Vanessa De Luque
    Sanabria, Judith
    Fernandez, Maria Carmen
    Castiella, Augustin
    Zapata, Eva
    Hallal, Hacibe
    Montane, Eva
    Soriano, German
    Roman, Eva
    Navarro, J. M.
    Jimenez, Miguel
    Prieto, Martin
    Conde, Isabel
    Aldea, A.
    Moreno, Jose M.
    Romero-Gomez, Manuel
    Gomez-Dominguez, Elena
    Lucena, M. Isabel
    Andrade, Raul
    HEPATOLOGY, 2017, 66 : 426A - 426A
  • [25] Phenotypic and genotypic characterization of drug-induced liver injury (DILI) with autoimmune features
    Stephens, C.
    Ortega, A.
    Medina-Caliz, I.
    Diaz, Mercedes Robles
    Castiella, Agustin
    Otazua, Pedro
    Zapata, E.
    Gomez-Moreno, E. M.
    Lopez-Nevot, MAngel
    Ruiz-Cabello, Francisco
    Soriano, German
    Roman, E.
    Hallal, Hacibe
    Maria Moreno-Planas, Jose
    Prieto, Martin
    Lucena, M. I.
    Andrade, Raul J.
    HEPATOLOGY, 2015, 62 : 499A - 499A
  • [26] Sex disparity and drug-induced liver injury
    Floreani, A.
    Bizzaro, D.
    Shalaby, S.
    Taliani, G.
    Burra, P.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (01) : 21 - 28
  • [27] Idiosyncratic Drug-Induced Liver Injury: Is Drug-Cytokine Interaction the Linchpin?
    Roth, Robert A.
    Maiuri, Ashley R.
    Ganey, Patricia E.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 360 (02): : 368 - 377
  • [28] Predicting idiosyncratic drug-induced liver injury - some recent advances
    Chen, Minjun
    Borlak, Juergen
    Tong, Weida
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) : 721 - 723
  • [30] Biomarkers of idiosyncratic drug-induced liver injury (DILI)-a systematic review
    Atallah, Edmond
    Freixo, Cristiana
    Alvarez-Alvarez, Ismael
    Cubero, F. J.
    Gerbes, Alexander L.
    Kullak-Ublick, Gerd A.
    Aithal, Guruprasad P.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (11) : 1327 - 1343